不同感染性疾病对女性性功能影响的临床研究

The influence of different infectious diseases on female sexual function

目的:探讨不同感染性疾病对女性性功能的影响以及干预方法,改善女性性功能状况。方法:选取女性泌尿生殖系感染性疾病患者406例,根据感染部位分为阴道炎183例、宫颈炎99例、盆腔炎87例、STDs 37例,采用《国际女性性功能评估量表》对406例女性性功能进行评价,统计四组患者性功能障碍发生率以及3个月内性高潮频率。且将其中性功能障碍患者随机分为A、B两组各65例,A组积极治疗炎症,B组在A组基础上给予心理疏导。结果:STDs及阴道炎患者性欲、性唤起、性生活频率、性生活接受度、性高潮、性关系满意度、性行为症状出现得分均明显低于宫颈炎和盆腔炎患者;阴道炎和STDs患者有性功能障碍发生率、3个月内无性高潮患者比例均明显高于宫颈炎和盆腔炎患者,两组比较差异有统计学意义(P<0.05)。A、B两组性功能障碍患者在自身年龄、伴侣年龄、性生活年限、分娩次数方面无明显差异,经过干预,A组患者性功能障碍17例(26.15%),B组患者10例(15.38%),A组患者没有性高潮者12例(18.46%),B组7例(10.77%),两组差异有统计学意义(P<0.05)。结论:阴道炎及STDs患者相较于其他感染性疾病更容易影响性功能,在积极治疗感染的同时给予患者心理干预,有利于改善患者性功能。

Objectives： To investigate the influence of different infectious diseases and interventions on fe male sexual function to improve female sexual function. Methods： 406 patients with infectious diseases of female urogenital system were selected. According to the site of infection, there were 183 cases of vaginitis, 99 cases of cervicitis, 87 cases of pelvic inflammatory disease and 37 cases of STDs. The International Female Sexual Function As-sessment Scale was used to evaluate female sexual function. The incidence of sexual dysfunction and the orgasm frequency within three months of the four groups were analyzed. Sexual dysfunction patients were randomly divided into group A and group B with 65 cases in each group. Group A received aggressive treatment of inflammation, and group B received psychological counseling on the treatment basis of group A. Results： The arousal, frequency of sexual activity, sexual acceptance, orgasm, sexual relationship satisfaction, sexual symptoms scores of patients with STDs and sexual vaginitis were significantly lower than these of cervicitis and pelvic inflammatory patients ; the inci- dence of sexual dysfunction, the proportion of patients orgasm wilrin three months of vaginitis and STDs patients were significantly higher than these of cervicitis and pelvic inflammatory patients, with statistically significant difference （ P 〈 0.05 ）. There was no statistically significant difference between group A and group B in their age, partner age, sex life and number of delivery. After the intervention, there were 17 cases （26.15%） of sexual dysfunction in group A and 10 cases （ 15.38 % ） in group B. There were 12 cases （ 18.46% ） without an orgasm in group A and 7 cases （ 10.77% ） in group B. The difference was statistically significant （ P 〈 0. 05 ）. Conclusion： Compared with other infectious diseases, the sexual function of patients with vaginitis and STDs are more easily affected. Psychological intervention is conducive to improving the sexual function of patients who receive positive treatment of infections at the same time.